About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, February 16th, 2012

The QualityStocks
Daily Stock List

graphic
graphic

Bio-Path Holdings, Inc. (BPTH)

Daily Markets reported previously on Bio-Path Holdings, Inc. (BPTH), and today we are highlighting the Company as "One to Watch" here at the QualityStocks Daily Newsletter.

Bio-Path Holdings, Inc. is a biotechnology company founded with technology licensed from The University of Texas MD Anderson Cancer Center. The Company focuses on developing therapeutic products utilizing their proprietary liposomal delivery technology designed to distribute nucleic acid drugs systemically throughout the human body with a simple intravenous transfusion. Bio-Path Holdings has their corporate headquarters in Houston, Texas.

Bio-Path's mission is to identify promising new compounds to add to their pipeline and to achieve low cost, efficient development through Phase IIa clinical trials. Additionally, their mission is to form new strategic alliances that offer promising business potential and raise necessary capital.

Their neutral lipid delivery technology provides systemic distribution of nucleic acid drugs throughout the human body through simple intravenous transfusion. The Company's delivery technology applies to double stranded (siRNA) and single stranded (antisense) nucleic acid drugs. This technology has the potential to revolutionize the treatment of cancer and other diseases where the targets of disease are well characterized.

Bio-Path Holdings announced in December 2011 that results from Cohort 1 of the Phase I clinical trial of their lead product candidate, BP-100-1.01 (Liposomal Grb-2), were disclosed December 12, 2011 in a poster presentation at the 53rd Annual Meeting of the American Society of Hematology (ASH) held in San Diego, California. BP-100-1.01 is a novel, systemic liposomal antisense treatment for blood cancers including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS).

The trial is taking place at The University of Texas MD Anderson Cancer Center. The drug was well tolerated with no treatment-related serious adverse events reported and data suggests some possible anti-leukemia activity at a low starting dose.

Last week, Bio-Path Holdings announced that they completed treatment of the second dosage cohort in their Phase I clinical trial of BP-100-1.01 (Liposomal Grb-2). The drug was again well tolerated with no treatment-related serious adverse events reported and data continues to suggest some possible anti-leukemia activity.

We're tracking Bio-Path Holdings, Inc. (BPTH) on our radar screens as "One to Watch" here at the QualityStocks Daily Newsletter.

Bio-Path Holdings, Inc. (BPTH) closed Thursday's trading session at $0.35, up 16.28%, on 250 volume.  The average volume for the last 60 days is 25,991.  The 52-week low/high is $0.13/$0.55.

Neah Power Systems, Inc. (NPWZ)

Penny Dreamers reported yesterday on Neah Power Systems, Inc. (NPWZ), FeedBlitz, SmallCapVoice, Epic Stock Picks did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Neah Power Systems, Inc. is developing long-lasting, efficient, and safe power solutions for the military, transportation, and for portable electronics applications. The Company uses an innovative, patented, award-winning, silicon-based design for their Powerchip™ micro fuel cells. These fuel cells enable higher power densities, lower cost and compact form-factors, and can run in aerobic and anaerobic modes. Founded in 1999, Neah Power Systems has their headquarters in Bothell, Washington.

Neah Power Systems has grown to include a premier engineering and scientific team from around the world. Prototype development continues; the Company expects to make their energy products commercially available this year. The Company's markets include the Military, Mobile Life (business travelers and mobile professionals), First Responders, as well as Logistics. Neah Power Systems has won awards for their technology over the years. The most recent recognition was the Best of What's New award from the distinguished publication Popular Science.

The Company has been issued another patent from the U. S. Patent and Trademark Office (USPTO). The patent is titled "Liquid-liquid fuel cell systems having flow-through anodes and flow-by cathodes" (USPTO #7,968,248). With this patent issuance, Neah has twelve issued patents in the United States. This patent relates to the unique anaerobic (non-air breathing) capability of the Neah fuel cell. This patent further covers the Company's proprietary architecture where a liquid fuel and a liquid oxidant run the fuel cell independent of the environment of operation.

Neah Power Systems has added a strategic component to their corporate business model through offering licenses to potential customers to manufacture the Company's PowerChip™ technology. Traditionally, Neah Power has focused on an outsourced manufacturing business model. The intention of the shift to emphasize a licensing strategy is to take further advantage of existing third-party manufacturing capacity in the semiconductor industry.

Neah announced, in October 2011, that they appointed Col. Lamont Woody, US Army (Retired), most recently a principal of the Laconia Group, as their defense advisor to their Board of Directors. Col. Woody will advise Neah Power Systems in international defense and government relations and various potential collaboration, partnership, and business development opportunities.

Neah Power Systems, Inc. (NPWZ) closed Thursday's session at $0.01, up 17.65%, on 253,188 volume with 9 trades.  The average volume for the last 60 days is 318,688.  The 52-week low/high is $0.001/$0.07.

HWI Global, Inc. (HWIC)

Stock Brain reported this week on HWI Global, Inc. (HWIC), HEROSTOCKS, Liquid Pennies, Stockhunter.us did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

HWI Global, Inc. is a leader in clean room design engineering and construction. The Company serves clients in the Life Science, Health Science, Nanotechnology, Microelectronics, and Aerospace industries. They have effectively constructed classified facilities for R&D, food & beverage, contract manufacturers, and OEM providers. Incorporated in 2004, HWI Global lists on the OTCBB and the Company has their corporate headquarters in Pittsburgh, Pennsylvania.

In 2004, Haddad-Wylie Industries, LLC, (HWI) formed with the intent to provide products with higher aseptic detail for the Life & Health Science/Semi-conductor Industries with the goal of designing and building clean rooms for a variety of clients. On December 28, 2010, Haddad-Wylie Industries merged into IVTSoftware.  In June of 2011, IVTSoftware became HWI Global and began trading under the symbol HWIC on the OTC. 

HWI Global provides value-engineered solutions for any custom clean room condition. This is from low volume sterile compounding to high volume manufacturing and packaging applications. The Company and their network of subject matter experts (from leading architects, engineers, facilities planners, and specialized installers) effectively design and construct state-of-the-art clean environments in a "turnkey" fashion.

HWI Global offers an assortment of clean room products. These include Bio-Gard™ PVC wall laminate, modular wall systems, aseptic high-density polyethylene shelving, aseptic wainscoting, high pharma systems with epoxy floors, and seamless welded sheet vinyl flooring. These also include heavy-duty rod-hung ceiling grid, installed continuous particle monitoring systems, all clean room furnishings and accessories, window modules, as well as a host of other products.

The Company also has their HWI SmartGrid. This is their extreme efficiency Ultra-Green Clean Room lighting system. The new innovative hybrid is considered a "green solution" to traditional fluorescent and incandescent lighting. The expectation is that the low temperature, environmentally friendly, high efficiency LED creation will reduce eyestrain, power consumption, and radiant heat in the clean room environments.

Last November, HWI Global announced they were awarded the contract to provide specialized design and build construction services for the new KCC B2-Stem Cell Cellular Therapy Laboratory Renovations at Mt. Sinai Medical Center. This project is running simultaneously with a second project HWI was recently awarded, a USP 797 sterile compounding clean room renovation. HWI currently holds the annual preventative maintenance contract for the 6th Floor Pharmacy clean room.

HWI Global, Inc. (HWIC) closed Thursday's trading session at $0.04, down 39.83%, on 3,845,562 volume with 351 trades.  The average volume for the last 60 days is 433,688.  The 52-week low/high is $0.01/$0.50.

TapImmune Inc. (TPIV)

Stock Brain and Liquid Pennies reported recently on TapImmune Inc. (TPIV), Stockhunter.us, HEROSTOCKS, WiseAlerts did earlier, and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.

TapImmune Inc. is a vaccine technologies company that lists on the OTC Bulletin Board.  The Company specializes in the development of innovative gene based immunotherapeutics and vaccines in the areas of oncology and infectious disease. Their lead product candidates include vaccines designed to restore and augment antigen presentation and subsequent recognition and killing of cancer cells by the immune system. TapImmune is based in Seattle, Washington.

At present, the Company is preparing for the start of a Phase 1 immunotherapy clinical trial targeting Her2Neu in breast cancer using a patented technology developed at the Mayo clinic. In August 2011, the FDA approved an IND (Investigational New Drug application) and TapImmune signed a sponsored research agreement with the Mayo Clinic for the Phase 1 Her2Neu Breast Cancer Clinical Trial, scheduled to start in this first quarter of 2012. TapImmune has the exclusive Option to license this technology. They are also developing TAP-based prophylactic vaccines commercially suitable for the prevention of infectious diseases and as Biodefense agents.

As a vaccine component, the gene based TAP technology has the potential to improve significantly the efficacy of prophylactic and immunotherapeutic vaccines as it addresses a fundamental mechanism for T cell recognition and response. TAP expression, unlike other vaccine technologies that address only the initiation of immune responses, also has the unique ability to enhance the effector function of mature killer T cells. This enhancement of effector function is potentially complementary to any/all vaccine approaches designed to enhance cellular responses.

Consequently, TapImmune envisions establishing multiple collaborative partnerships as they progress gene-based TAP development and research in the clinic. The exploitation of this key mechanism is highlighted by two collaborations with the Mayo Clinic in Rochester, Minnesota and their progress in 2011.

In November 2011, TapImmune announced that Mr. Mark Reddish joined the Company's Management Team as Vice President of Product Development. Mr. Reddish was formerly Vice President of Product Development and Principal Investigator, Biodefense at ID Biomedical, Bothell, Washington, prior to the acquisition of the company by Glaxo SmithKline for $1.6 billion.

TapImmune Inc. (TPIV) closed Thursday's trading session at $0.17, down 1.69%, on 29,100 volume with 6 trades.  The average volume for the last 60 days is 97,374.  The 52-week low/high is $0.10/$0.39.

Pilot Gold Inc. (PLG.TO)

Today we are reporting on Pilot Gold Inc. (PLG.TO), here at the QualityStocks Daily Newsletter.

Pilot Gold Inc. is a gold exploration company that lists on the Toronto Stock Exchange. The Company's three key assets include interests in the Halilaga and TV Tower projects in Turkey, and the Kinsley Mountain project in Nevada, a gold system analogous to Long Canyon. In addition, the Company has a pipeline of projects, characterized by large land positions and district-wide potential. Pilot Gold has their corporate headquarters in Vancouver, British Columbia.

Since 2004, the team comprising Pilot Gold has played a key role in establishing the prospectivity and gold endowment of the Biga District in northwestern Turkey. This includes defining the Agi Dagi and Kirazli gold deposits. The Company is advancing the aforementioned Halilaga and TV Tower properties in the Biga District, which have significant growth potential. Teck Resources Ltd.'s Turkish subsidiary (TMST) is Pilot Gold's 60 percent joint venture partner for both projects.

Pilot God's Kinsley Mountain project in Nevada is a sediment-hosted, past producing gold system. The Company's exploration philosophy in Nevada is to focus on select deposit types marked by large land positions off main trends, and historic resources with high-grades at surface and district-wide potential.

Last week, Pilot Gold reported that their initial drilling returned impressive intervals of gold mineralization at Kinsley Mountain. This is a system the Company believes is strongly analogous to the nearby Long Canyon gold deposit in northeastern Nevada. Pilot Gold has an option to earn up to a 65 percent interest on the Kinsley Mountain project. Kinsley Mountain is approximately 90 kilometers to the southeast of Long Canyon.

Kinsley Mountain shares the same unique combination of stratigraphy, structure and mineralization as Long Canyon, a deposit the Company's technical team defined and advanced to a multi-million-ounce resource prior to its acquisition by Newmont Mining Corp. in April of 2011.

Kinsley Mountain is one of Pilot Gold's three priority assets to undergo advancement in 2012. The Company plans to advance Kinsley Mountain through detailed geological analysis, aggressive drilling and deposit modeling. The Kinsley Mountain project is under a joint venture option agreement with Nevada Sunrise Gold Corp. Pilot Gold anticipates earning an initial 51 percent interest in the project by Q2 2012.

Pilot Gold Inc. (PLG.TO) closed Thursday's trading at $1.74, down 2.25%, on 104,048 volume.  The 52-week low/high is $1.63/$1.78.

Liberator Medical Holdings, Inc. (LBMH)

Wall Street Resources reported this week on Liberator Medical Holdings, Inc. (LBMH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Liberator Medical Holdings, Inc. and their subsidiaries distribute direct-to-consumer durable medical supplies for seniors in the United States. Liberator Medical Supply Inc. is a wholly owned subsidiary of Liberator Medical Holdings. The Company offers more than 5,000 products to Medicare-eligible patient populations with chronic conditions requiring repeat-orders of maintenance supplies. Liberator Medical Holdings lists on the OTC Bulletin Board; the Company has their headquarters in Stuart, Florida.

Liberator Medical Supply established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. They are an Exemplary Provider™ accredited by The Compliance Team. Liberator has recognition for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance.

Liberator's revenue mainly comes from supplying products to meet the rapidly growing demand for urological, ostomy, mastectomy and diabetes patients. The Company communicates with patients and their physicians regularly regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.

Yesterday, Liberator Medical Holdings announced first fiscal quarter net revenues of $14.8 million. This represents an increase of $2.6 million, or 21.1 percent, compared with the first fiscal quarter of 2011. Gross profit for the first fiscal quarter, which ended December 31, 2011, increased by $1 million, or 13.0 percent, to $8.8 million, compared with gross profit of $7.8 million for the first fiscal quarter of 2011.

Net income increased from a loss of ($202,000) for the first fiscal quarter of 2011 to a profit of $454,000, or $0.01 per share, for the first fiscal quarter of 2012. The loss for the first fiscal quarter 2011 included a non-cash charge against income of $902,000 for the change in fair value of derivative liabilities. As of December 31, 2011, the Company had current assets of $16.5 million and current liabilities of $5.4 million.

Liberator Medical Holdings, Inc. (LBMH) closed Thursday at $1.00, even with yesterday’s close, on 9,200 volume with 6 trades.  The average volume for the last 60 days is 17,747.  The 52-week low/high is $0.75/$1.55.

Castillian Resources Corp. (CT.V)

Today we are highlighting Castillian Resources Corp. (CT.V), here at the QualityStocks Daily Newsletter.

Castillian Resources Corp. is a Canadian mineral exploration company, which has gold and base metal properties in Canada and South America. The Company's flagship property is the Hope Brook Gold Project located in southwestern Newfoundland. Castillian has outlined an extensive new Gold-in-Soil anomaly trend on their Canadian Creek property in the Yukon that is adjacent to Kaminak's Sugar Gold-in-Soil trend. Castillian Resources lists on the TSX Venture Exchange. The Company has their corporate headquarters in Toronto, Ontario.

Concerning the Hope Brook Gold Project in Newfoundland, the Company has an extensive mineralized zone with significant past production. Six major target areas are outlined for drilling in the historic mine area. Castillian has experienced excellent results from three major zones in their ongoing $7.5 million, 25,000+m drill program. They have an option to purchase 100 percent interest in 993 claims covering approximately 25,000 ha.

In regards to their Canadian Creek Gold Project in the Yukon, drilling by previous operators has confirmed significant gold mineralization including 0.72 g Au/t over 55.3m. The highest new gold-in-soil value within the Canadian Creek trend is 0.97 g Au/t, with historic gold-in-soil values up to 2.29 g Au/t. A significant new gold-in-soil anomaly, the Canadian Creek trend, is 7.5 kilometers long by 2 kilometers wide. The major structural zone, greater than 10 kilometers along strike, is sub-parallel to the gold-in-soil trend.

This week, Castillian Resources announced their first National Instrument 43-101 (NI 43-101) compliant mineral resource estimate for their Hope Brook Gold Project in southwestern Newfoundland. The mineral resource estimate has its basis on 631 diamond drill holes totaling 124,801 meters of historic and recent drilling. This includes 77 surface diamond drill holes totaling 24,857 meters completed by Castillian in 2010 and 2011. Mineral resources have been estimated within a constraining pit shell at a cutoff grade of 0.50 grams gold per tonne (g Au/t) and below this shell at a cutoff grade of 2.0 g Au/t.

The estimation of total indicated mineral resources is at 290,000 ounces of gold. The estimation of total inferred mineral resources is at 740,000 ounces of gold.

Castillian Resources Corp. (CT.V) closed Thursday's trading session at $0.08, up 15.38%, on 1,010,428 volume.  The 52-week low/high is $0.10/$0.24.

Pilot Gold Inc. (PLG.TO)

Today we are reporting on Pilot Gold Inc. (PLG.TO), here at the QualityStocks Daily Newsletter.

Pilot Gold Inc. is a gold exploration company that lists on the Toronto Stock Exchange. The Company's three key assets include interests in the Halilaga and TV Tower projects in Turkey, and the Kinsley Mountain project in Nevada, a gold system analogous to Long Canyon. In addition, the Company has a pipeline of projects, characterized by large land positions and district-wide potential. Pilot Gold has their corporate headquarters in Vancouver, British Columbia.

Since 2004, the team comprising Pilot Gold has played a key role in establishing the prospectivity and gold endowment of the Biga District in northwestern Turkey. This includes defining the Agi Dagi and Kirazli gold deposits. The Company is advancing the aforementioned Halilaga and TV Tower properties in the Biga District, which have significant growth potential. Teck Resources Ltd.'s Turkish subsidiary (TMST) is Pilot Gold's 60 percent joint venture partner for both projects.

Pilot God's Kinsley Mountain project in Nevada is a sediment-hosted, past producing gold system. The Company's exploration philosophy in Nevada is to focus on select deposit types marked by large land positions off main trends, and historic resources with high-grades at surface and district-wide potential.

Last week, Pilot Gold reported that their initial drilling returned impressive intervals of gold mineralization at Kinsley Mountain. This is a system the Company believes is strongly analogous to the nearby Long Canyon gold deposit in northeastern Nevada. Pilot Gold has an option to earn up to a 65 percent interest on the Kinsley Mountain project. Kinsley Mountain is approximately 90 kilometers to the southeast of Long Canyon.

Kinsley Mountain shares the same unique combination of stratigraphy, structure and mineralization as Long Canyon, a deposit the Company's technical team defined and advanced to a multi-million-ounce resource prior to its acquisition by Newmont Mining Corp. in April of 2011.

Kinsley Mountain is one of Pilot Gold's three priority assets to undergo advancement in 2012. The Company plans to advance Kinsley Mountain through detailed geological analysis, aggressive drilling and deposit modeling. The Kinsley Mountain project is under a joint venture option agreement with Nevada Sunrise Gold Corp. Pilot Gold anticipates earning an initial 51 percent interest in the project by Q2 2012.

Pilot Gold Inc. (PLG.TO) closed Thursday's trading at $1.74, down 2.25%, on 104,048 volume.  The 52-week low/high is $1.63/$1.78.

graphic

The QualityStocks
Company Corner

graphic
graphic

Beacon Enterprise Solutions Group, Inc. (BEAC)

The QualityStocks Daily Newsletter would like to spotlight Beacon Enterprise Solutions Group, Inc. (BEAC). Today, Beacon Enterprise Solutions Group, Inc. closed trading at $0.30, up 6.38%, on 16,200 volume with 6 trades. The stock’s average daily volume over the past 60-days is 60,332 with a 52-week low/high of $0.14/$0.69.

Beacon Enterprise Solutions Group, Inc. (BEAC) specializes in designing, implementing and managing high performance Information Technology Systems ("ITS") infrastructure solutions. Offering national, multi-national and global, turnkey ITS infrastructure solutions, the company is capable of delivery professional services to Fortune 1000 and large multi-site firms as they increasingly single source and outsource to reduce costs while optimizing critical planning, design, program, project and construction management and managed services.

Leveraging standardization, rapid mobilization and a just-in-time professional services approach, Beacon Enterprise Solutions serves as a single source for national, multi-national and global enterprise clients, including special practices focused on data centers, campuses, smart buildings, outside plant, wireless systems and other technology-based applications and projects. Clients are provided with consistent and predictable results anywhere in the world. The company's solutions allow clients to focus on their core businesses without the distraction of having employees spend valuable time on services that Beacon can provide on any continent, in any country using any language.

Headquartered in Louisville, Kentucky, with regional headquarters in Cincinnati, Ohio, Dublin, Ireland, and Prague, Czech Republic, in addition to personnel located throughout the United States and Europe, Beacon Enterprise Solutions services a diverse range of clients. For more than 30 years, the company has enabled businesses in a variety of vertical markets to dramatically reduce costs, enable global standardization, manage day-to-day technology systems moves, adds and changes, and take on major projects – all under a single national, multi-national or global agreement.

Beacon Enterprise Solutions has carefully assembled a seasoned management team and operating strategy to maximize organic growth and new business development across multiple vertical markets. More than 4,000 companies, from small businesses to Fortune 50 firms, have chosen the company's solutions. Disclaimer

Beacon Enterprise Solutions Group, Inc. Blog

Beacon Enterprise Solutions Group, Inc. News:

Beacon Enterprise Solutions Reports 36% Increase in Blended Project Funnel

Beacon Enterprise Solutions Hires Industry Sales Veteran

Beacon Enterprises Solutions Group, Inc. Announces 97% Increase in Gross Profits and 51% Increase in Net Sales for Fiscal Q1 2012

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.01, even for the day, on 802,139 volume with 20 trades. The stock’s average daily volume over the past 60-day daily average volume is 238,976 with a 52-week low/high of $0.001/$0.0205.

Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.

Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.

In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings wholly-owned subsidiary Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming

Consorteum Holdings Completes Acquisition of Tarsin Inc.

Consorteum Holdings, Inc. Announces Lead Spokesman for the First Nations MasterCard Program

GlobalWise Investments, Inc. (GWIV)

The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments closed trading at $1.30, even for the day, on 250 volume with 2 trades. The stock’s average daily volume over the past 60-day daily average volume is 209 with a 52-week low/high of $1.20/$1.50.

GlobalWise Investments, Inc. (GWIV) via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.

GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.

The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.

GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer

GlobalWise Investments Company Blog

GlobalWise Investments News:

GlobalWise Completes Acquisition of Intellinetics

eVero Announces a Strategic Partnership with Intellinetics

Intellinetics Announces William J. Santiago (BJ) as New President and CEO

TiVUS, Inc. (TIVU)

The QualityStocks Daily Newsletter would like to spotlight TiVUS, Inc. (TIVU). Today, TiVUS, Inc. closed trading at $0.0002, even for the day, on 11,853,225 volume with 15 trades. The stock’s average daily volume over the past 60-day daily average volume is 23,838,942 with a 52-week low/high of $0.0001/$0.06.

TiVUS, Inc. (TIVU) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.

The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.

By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.

The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer

TiVUS, Inc. Company Blog

TiVUS, Inc. News:

TiVUS' Ad-Insertion Attracts Diverse Range of Advertisers

TiVUS' First Ad-Insertion Revenues Begin - Hotel TV advertising embraced by local merchants

TiVUS Commences Live Hotel TV Ad-Insertions

NeoGenomics, Inc. (NGNM) Posts Financial Strength in Q4, FY 2011

NeoGenomics, a high-complexity CLIA–certified clinical laboratory specializing in cancer genetics diagnostic testing, today reported its results for the fourth quarter and full year 2011.

“We are very pleased with our Quarter 4 results. For the third quarter in a row we posted the largest year-over-year and sequential quarterly increases in revenue in our corporate history, and our revenue growth rate continued to accelerate throughout the quarter,” Douglas M. VanOort, the company’s chairman and CEO stated in the press release. “Our sales teams were also more productive, as we achieved excellent revenue growth while keeping sales and marketing costs essentially unchanged from Quarter 4 last year. The improved operating leverage from our SG&A expenses allowed us to return to profitability.”

The company posted fourth-quarter revenue at $12.9 million, up 47 percent compared to fourth-quarter revenue of $8.8 million reported for 2010.

Net income for the 2011 fourth quarter was $152,000, or $0.00 per share, compared to a net loss of $377,000 or ($0.01) per share, reported for the fourth quarter of last year. Adjusted EBITDA increased by more than $1.0 million to $1.1 million from $29,000 last year.

For the full year 2011, NeoGenomics reported revenue of $43.5 million, a 27 percent increase over 2010 revenue of $34.4 million.

The company reported a 2011 net loss of $1.2 million or ($0.03) per share, compared to a net loss of $3.3 million or ($0.09) per share in 2010. Adjusted EBITDA for the year increased by $2.7 million to $2.1 million from a loss of $566,000 reported in 2010.

“Our performance improved steadily throughout the year with revenue growth rates and gross margin increasing sequentially in each of the four quarters of 2011,” VanOort continued. “Although average revenue per test declined in 2011, we were able to offset most of that impact with increases in productivity. We also maintained tight cost control throughout 2011. SG&A expense for the full year increased only slightly from 2010, and nearly half of the increase was for normal bad debt expense associated with the strong increase in revenue.”

The Company expects revenue between $54 million – $59 million and net income of $0.02 – $0.04 per share for 2012. For the fiscal first quarter, NeoGenomics said it expects revenue of $13.5 million – $14.0 million and net income of $0.00 to $0.01 per share.

“We believe we are well positioned for continued success. Our current sales pipeline is healthy, and we plan to launch several new sales and marketing initiatives to expand our strategic partnerships with large clients. We also expect a stable reimbursement environment this year, which should allow us to make further improvements in gross margin and profitability. In addition, we plan to significantly expand our molecular and immunohistochemistry test menus, launch the second test under our agreement with Abbott Molecular, and make important investments to begin developing the technology and tests we licensed from Health Discovery Corp,” VanOort stated.

China Health Resource, Inc. (CHRI) Posts Q4, FY Estimated Earnings

China Health Resource, a developer and provider of raw and pharmaceutical TCM products, today announced unaudited financial results for the fourth quarter and year ended December 31, 2011.

The company expects 2011 fourth-quarter operating revenues of more than $12.5 million, a 218 percent increase compared to the fourth quarter of 2010. For full year 2011, the company expects operating revenues of $34.9 million, a 241 percent increase over 2010 revenues.

China Health expects 2011 fourth-quarter net income to be $2.7 million, or $0.015 per fully diluted common share, compared with $1.6 million or $0.01 per share, reported for the fourth quarter of 2010. For full year 2011, the company anticipates net income of $6.8 million, or $0.038 per fully diluted common share, compared with a net income of$2.7 million, or $0.02 per share in the year prior.

The company attributes its growth to the expansion of its TCM product lines, improvements in sales channel management to extend market reach, and consistent cost controls.

China Health also provided guidance for 2012 with a focus on growing its product lines and implementing further growth initiatives.

The company anticipates 2012 earnings in the range of $0.06 and $0.065 per share.

Jiayin Wang, President and CEO of CHRI, stated, “Speaking to the company’s focus in 2012, we will continue to maintain our leadership in our DAR franchise while we grow our product lines with valuable and high growth products like Gastrodiae. In addition, we will pursue growth opportunities worldwide through acquisition and distribution and grow in areas where we can best serve customers and create value.”

China Health said it will provide detailed results in its final 2011 fourth quarter and year-end earnings press release and 10-K filing.

Spalding Surgical Center Goes Paperless with MMRGlobal, Inc.'s (MMRF) Document Managing and Imaging System

MMRGlobal, Inc. announced that leading Southern California outpatient general surgery center Spalding Surgical Center of Beverly Hills is going paperless with MMRPro, MMR’s document management and imaging system. MMRPro is a health IT system designed for hospitals, doctors’ offices, and other healthcare facilities to help lessen rising healthcare costs, improve efficiency, and allow doctors and patients to electronically track results and wellness progress.

Increased use of digitization is rendering pen-and-paper recordkeeping more and more obsolete, and MMRPro is designed to let physicians convert to computerized records without greatly altering the look and feel of a practice’s operations. So far, MMRPro has improved staff productivity at Spalding, enabling office and staff personnel to process information much more quickly and store patient records online more easily – leaving more time and attention for patient care.

MMR will exhibit its suite of health IT products, including a demonstration of MMRPro and its capabilities to transform healthcare facilities into paperless offices with or without a full-featured EMR, at the HIMSS Conference and Exhibition, Feb. 20-24 in Las Vegas. During the conference, MMR will also launch phase 2 of its MMR Stimulus Program, which allows MMR Stimulus Program participation for hospitals that are using selected EMR systems to integrate the MMRPatientView patient portal as a standalone module.

MMRGlobal, Inc. is leading provider of Personal Health Records (PHRs) and electronic document managing and imaging systems designed for professionals in the healthcare field. The company provides secure and user-friendly online PHRs and electronic safe deposit box storage solutions through its wholly owned operating subsidiary MyMedicalRecords, Inc., serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups.

Utilizing proprietary, patented technologies, MyMedicalRecords allows transmission and storage of documents, images, and voicemail messages using various methods, including fax, phone, and file upload; this is accomplished without reliance on any specific electronic medical record platform to populate a user’s account. As an independent software vendor partner with Kodak, MMR delivers an integrated turnkey EMR solution for healthcare professionals.

AUXILIO, Inc. (AUXO) Brings Total Managed Print Services to U.S. Hospitals, Streamlining Operational Costs

AUXILIO is a brilliant company with a strong lead as a true pioneer in Managed Print Services (MPS), specifically for the healthcare industry. With a solid focus on the true bottom line, client retention, AUXO boasts an impressive 100% retention rate among hospital partnerships, thanks in large part to the company’s rigorousness in the ferreting out of hidden costs and MPS process inefficiencies.

With print volume reduction programs and key Centers of Excellence, staffed with professional print strategy consultants to devise unparalleled solutions for the requirements of each individual client, the company’s laser-focus on nurturing client caregiver efficiency is only made all the bolder by a continuing commitment to the environment through eco-friendly/e-waste initiatives.

A streamlined and integrated approach to managing/monitoring vital processes in copy, print, and scan infrastructures is provided when AUXILIO steps in. The complex landscape of requirements is solved and the company’s team of experts goes to work; individual hospital units control the purchase and lease of hardware, IT/material management personnel handle supplies, while clinical units handle testing of CAT and MRI functionality/output. The result is a streamline “best use system” that solves the difficult cost equation for profit and usability.

The remarkable cost efficiencies AUXO is able to produce are the result of a firm, hands-on approach developed by the company during its rise to prominence. Indeed, the hallmark of excellence for which AUXO is most widely known is this keen ability to bring high-resolution transparency to the entire spectrum of staff productivity.

As a standard bearer within the industry for cost containment, vendor management, and process refinement, the company strives to apply its well-developed business model, working hand-in-hand with hospital executives to obtain the optimum cost containment envelope for a given operation. There are no upfront fees or unseen risks down the line, only predictable costs and real consistency ensuring the quality of end-user experiences/overall quality of patient care.

Recently, AUXO has seen enthusiasm from the industry in the form of major deals like the recent $40M, five-year contract with Catholic Health East (CHE) to roll out its impressive MPS solutions across 19 CHE facilities. An announcement which quickly followed the $5M, five-year, Memorial Health System (Colorado Springs, CO) agreement from the day before.

The reputation amassed thus far speaks volumes, as healthcare providers turn to AUXO to help shore up costs, confident in the company’s ability to provide intelligent MPS solutions within a risk-free environment where savings are guaranteed. Assuming all print business environment costs via its highly adaptive, customized service integration platform, AUXO is able to stabilize rates at fixed levels unmatched in the industry. As the company continues to innovate, the clients in AUXO’s portfolio of some 1,300 or more U.S. hospitals will continue to benefit.

For more information on this company, or to stay up to date on the latest news and information, please visit AUXILIO’s website at: www.AuxilioInc.com

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

SmallCap Fortunes
(NWCN )

2.

OTCPicks
(ECDC)

3.

WiseAlerts
(ADRN)

graphic
By The Numbers Charts
QualitystockTwits

Daily Sponsors

The QualityStocks By The Numbers Report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251